Paradigm Biocapital Advisors LP Ocular Therapeutix, Inc Transaction History
Paradigm Biocapital Advisors LP
- $2.14 Billion
- Q2 2025
A detailed history of Paradigm Biocapital Advisors LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 3,420,340 shares of OCUL stock, worth $43.5 Million. This represents 1.48% of its overall portfolio holdings.
Number of Shares
3,420,340
Previous 1,314,018
160.3%
Holding current value
$43.5 Million
Previous $9.63 Million
229.56%
% of portfolio
1.48%
Previous 0.49%
Shares
2 transactions
Others Institutions Holding OCUL
# of Institutions
203Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$182 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$177 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$162 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$146 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$107 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $978M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...